rapid gastrointestinal disease test / Clostridium difficile / stool / molecular



  • Applications:

    for gastrointestinal diseases

  • Tested parameter:

    Clostridium difficile

  • Sample type:


  • Analysis mode:



The ARIES® C. difficile Assay is an easy to use molecular assay for the direct detection of toxigenic Clostridium difficile nucleic acid in stool samples using a sample to answer platform
Clostridium difficile infections (CDI) are potentially life-threatening health risks that tend to occur in people who have taken antibiotics or been admitted to hospitals. In fact, CDI accounts for 15-25% of all antibiotic associated diarrhea and is the most common cause of infectious diarrhea in a healthcare setting.1 The rising prevalence of these colitis-inducing infections is cause for concern, as is the estimated $1 billion in healthcare costs they cause.2